Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Breast Carcinoma: early-phase trial registry
63 of 107 indexed Breast Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #120 of 28,707 conditions by registered trial count.
107 US clinical trials · 63 currently recruiting · #120 of 28,707 conditions by registered trial count
Breast Carcinoma: 107 US clinical trials tracked, 63 recruiting.
Breast Carcinoma is the subject of 107 registered US clinical trials on ClinicalTrials.gov, 63 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 33 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 21 of these trials.
Enrollment posture brief
Registry condition breast-carcinoma
OPEN 63 | RECR 59% | LATE 5 | EARLY 33 | RANK #120 | SPON 21
Volume-matched condition peers
Nearest open-share peer: Alcohol Use Disorder (59% recruiting · 185 trials)
Breast Carcinoma lists 63 open slots (59% of 107 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Breast Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Breast Carcinoma is recruiting above its size-band peers.
63 of 107 indexed trials (58.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Breast Carcinoma research.
Mayo Clinic accounts for 21 of 107 trials (19.6%). 30 distinct sponsors appear on at least one study for this condition label.
-
Typical Breast Carcinoma enrolment sits around 126 participants.
Median target enrolment is 126 among the 107 trials that report a genuine target (sentinel values excluded). 45 of those (42.1%) plan for fewer than 100 participants.
-
Breast Carcinoma research is mostly interventional.
77 interventional and 30 observational studies make up this index (72% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
107 total, page 3 of 3
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
Ohio State University Comprehensive Cancer Center
NCT05086705
Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery
Ohio State University Comprehensive Cancer Center
NCT05583981
Topical Keratin in Treating Radiation Dermatitis in Patients With Breast Cancer
Wake Forest University Health Sciences
NCT03374995
Diffusion Tensor Imaging in Predicting Development of Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer (CIPN)
University of Arizona
NCT03365895
ACY-1215 + Nab-paclitaxel in Metastatic Breast Cancer
Columbia University
NCT02632071
Clinical Outcomes for Offering Genetic Testing in a Tiered Approach
Fred Hutchinson Cancer Center
NCT04902144
Provider Training in Increasing Patient Tobacco Cessation Counseling and Referrals for Patients With Cancer Undergoing Radiation Therapy
OHSU Knight Cancer Institute
NCT03135782
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 15 |
| Phase 2 | 18 |
| Phase 3 | 5 |
Top Sponsors
Named interventions
Most-linked intervention names on Breast Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Breast Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Breast Carcinoma page
107 registered trials, 63 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 63 Breast Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Breast Carcinoma trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Breast Carcinoma condition card totals 107 registered trials; most-linked intervention Questionnaire Administration; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.